Published: March 5th 2024 | Updated: March 31st 2025
FDA Approves First Denosumab Biosimilars
Published: March 23rd 2025 | Updated: March 31st 2025
Patients With IBD Maintain Therapy 2 Years Post Switching to Infliximab Biosimilar
Published: March 16th 2025 | Updated: March 31st 2025
Retina Specialists’ Evolving View on Biosimilars in AMD Treatment
Published: February 25th 2025 | Updated: March 31st 2025
Biosimilar Approvals Streamlined With Advanced Statistics Amidst Differing Regulatory Requirements
Published: February 25th 2025 | Updated: March 31st 2025
3 Ustekinumab Biosimilars Launch on US Market
Published: February 23rd 2025 | Updated: March 31st 2025
Will the FTC Be More PBM-Friendly Under a Second Trump Administration?